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Maine’s HighRisk Infants
and Maternal
Health and
Wellbeing:
The Maine Infant
Follow-Up Project
by Beth A. Logan

The Maine Infant Follow-Up Project is a researchbased effort to accelerate early identification of developmental risk for infants whose mothers use drugs or
alcohol. These infants are at high risk for neurodevelopmental disorders, and early identification will
enable early-early intervention. Targeted interventions will increase the chance for children to catch up
developmentally during the period of most rapid
brain growth in the first three years of life.
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M

aternal and child health is profoundly affected
by Maine’s regional landscape of intergenerational rural poverty and limited health care access.
Economic and social disadvantage is all too common in
Maine families and can derail the path to normal child
development. Maine’s rate of infant mortality in the
first year is high, but similar to U.S. rural states, with
leading causes being congenital anomalies, prematurity,
sudden infant death syndrome (SIDS), and pregnancy
and delivery complications.
According to the Web-based Injury Statistics
Query and Reporting System (WISQARS) of the U.S.
Centers for Disease Control and Prevention (www.cdc.
gov/injury/wisqars/), SIDS in Maine represents 10
percent of all infant deaths compared to only 5.4
percent in the northeast region. Because of the known
association of SIDS and prenatal alcohol and drug
addiction (Hunt and Hauck 2006), Maine’s elevated
SIDS rate may reflect an acquired brain injury that is
driven largely by poor maternal health, lifestyle, and
economic adversity.
Although Maine has implemented policy changes
to address the leading cause of infant death (i.e.,
congenital anomalies) with mandated statewide
screening for a host of genetic and metabolic disorders
at the time of birth, at present there is no public policy
that mandates screening for long-term consequences of
prenatal poverty-related risk factors (e.g., alcohol,
tobacco, abuse of opiates and other substances, lack of
prenatal care, malnutrition, and domestic abuse).
Maine’s spiraling need for services for developmental
disabilities and special education (Maine Department
of Education 2007) poses a crisis of care for early identification of developmental and behavioral disorders
related to maternal addiction.
Regionally, northeastern Maine families show
exceptionally low socioeconomic status (e.g., poor
employment and education achievement; receipt of
public assistance and Medicaid) that is correlated with
alcohol, tobacco, and drug addiction (Hayes et al.
2002; Troese et al. 2008). During pregnancy and
immediately after birth, unregulated drug and alcohol
exposure of the developing child is probabilistically
(dependent on genetic susceptibility, dose, and timing)
related to neurological damage (e.g., poor respiratory
and cardiac function associated with prematurity, and

Maine’s spiraling
cognitive and motor deficits
associated with oxygen deprivation), leading to developmental
disabilities later in childhood.
PRESCRIPTION OPIATE
EPIDEMIC AND PRENATAL
EXPOSURES

A

need for services
for developmental
disabilities and
special education poses a crisis

n increasingly large group
of care for early
of Maine infants are being
exposed to prescription opiates
identification of
as addiction reaches epidemic
proportions statewide. Hospital
developmental
admissions for prescription drug
abuse increased 206 percent
and behavioral
between 2004 and 2008 (Maine
Department of Health and
disorders related to
Human Services 2009). In the
most recent National Survey
maternal addiction.
on Drug Use and Health in
Maine (2006–2007), 4.6 percent
of those 12 or older (52,000
people) reported having used
pain relievers nonmedically in the past year (Hughes,
Sathe and Spagnola 2009). Young adults of childbearing
age constitute the largest group of opiate-addicted
patients, with 92 percent of the 500 women in treatment in Acadia Hospital’s Narcotics Treatment Program
(NTP) in Bangor being of childbearing age, and approximately 15 percent being pregnant at any given time.
The standard of care for pregnant women with
opiate addiction is methadone maintenance through
enrollment in a narcotics treatment program. Careful
dosing of methadone matches the increasing metabolic
demands of the growing fetus. In contrast, untreated
opiate abuse (typically in a background of co-occurring
maternal tobacco and alcohol abuse) exposes the fetus
to repeated binge and withdrawal episodes responsible
for high rates of in utero fetal death (Oei and Lui
2007). After birth, opiate-dependent infants are at high
risk for numerous adverse effects, including a
protracted withdrawal process. The severity of withdrawal is compounded by maternal psychiatric diagnosis requiring antidepressant and anti-anxiety
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medications such as Prozac and benzodiazepines, which
have their own withdrawal syndromes.
THE MAINE INFANT FOLLOW-UP PROJECT:
EVALUATING RISK STATUS IN CHILDREN

T

he Maine Infant Follow-up Project is an effort to
provide a longitudinal framework to accelerate the
early identification of developmental risk to include
the prenatal and early infancy period so that early-early
intervention can be initiated. To date, our work has
included more than 200 alcohol- and opiate-exposed
infants and involves an interdisciplinary team with
leadership from Dr. Mark Brown, chief of pediatrics at
Eastern Maine Medical Center; Dr. Paul Tisher, former
chief of psychiatry at Eastern Maine Medical Center
and chief medical officer at Acadia Hospital; and the
Maine Institute for Human Genetics and Health and
University of Maine infant development team led by
Marie Hayes. As part of our joint efforts to identify
high-risk infants, we have characterized both prenatal
substance exposure and environmental risk factors in
different samples of northeastern Maine families. In the
first study, disadvantaged women and their infants were
studied from pregnancy onward with the goal of understanding the complex relationship between infant brain
development, demographic risk, and prenatal exposure
to alcohol and tobacco. In the second study, we again
evaluated demographic and alcohol/tobacco risk in the
context of opiate addiction, with an expanded suite of
markers of brain development.
These two study cohorts were similarly exposed to
rural poverty, as evidenced by their demographic characteristics. Groups were also similar on measures of
psychological wellbeing, as indicated by scores on the
Beck Depression Inventory, second edition (BDI-II), a
screen for maternal depression.
In the first cohort, women were recruited from
the Family Practice Clinic (FPC) of Eastern Maine
Medical Center (EMMC), which serves low-income
families from primarily Washington, Hancock, and
Penobscot counties. Pregnant women were Caucasian
(93 percent), single (64.7 percent), young (<26 years =
70.3 percent), unemployed (48 percent), and dependent on Medicaid (MaineCare) or had no health insurance (81.6 percent).
62 · Maine Policy Review · Summer/Fall 2009

The second study was conducted in a cohort of
families enrolled in the narcotics treatment program
(NTP) at the Acadia Hospital in Bangor. The NTP
serves primarily low-income, white families (97
percent Caucasian), ages 12 to 65, 47 percent female,
from northeastern Maine. Mothers in this cohort were
in recovery treatment for opiate addiction at Acadia
NTP and were maintained on methadone during
their pregnancies.
The groups did not differ statistically in tobacco
use or pre-pregnancy or pregnancy estimates of alcohol
use. Rates of tobacco and alcohol use in both samples
were high, but similar to those of women of the same
social class (SAMHSA 2008). The two study groups
differed primarily in opiate and other illicit drug use
pre-pregnancy, with the Acadia NTP group differing
statistically in the use of opiates and other illicit drugs
pre-pregnancy (opiates, marijuana, cocaine, and inhalants) from the FPC group. Hence, this comparison,
allows us to study differences in outcomes for these
infants that are unique to opiate and other polydrug
exposure, given the samples are similar in alcohol,
tobacco, and environmental risk factors.
Women had structured interviews during the
third trimester with questions about their psychological health and the quantity, frequency, and timing
of tobacco, alcohol and other substances both prepregnancy and during pregnancy, along with questions about tolerance and addiction to alcohol. These
measures assess problem drinking and have been
demonstrated in the literature to be valid indicators
of the amount and severity of prenatal exposure
(Jacobson and Jacobson 1996). Alcohol has wellestablished detrimental effects on brain development
known as fetal alcohol syndrome/alcohol-related
neurodevelopmental disorder (FAS/ARND) (May
and Gossage 2001). Additionally, data from routine
random urine analyses (UA), which screen for marijuana, methadone, oxycodone, other opiates, benzodiazepines, cocaine, and stimulant medications were
collected. The most commonly detected illicit drug
detected in UA screens was marijuana, followed by
benzodiazepines and other opiates.
The first study found that infants whose mothers
had high alcohol use patterns before and during pregnancy exhibited fragmented and unstable sleep along
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FIGURE 1: Treatment Rate for Neonatal Abstinence Syndrome,

by Prenatal Exposure (November 2007–November 2008)

No Treatment

Treatment Rate

with fewer normal sleep movements.
100%
Infants were sleep deprived, indicated
by decreased alertness and increased irri90%
tability during the day. Tobacco
smoking during pregnancy, present in
80%
54 percent of the mothers, was associ70%
ated with increased infant drowsiness
associated with difficult transitions
60%
between sleeping and waking. Sleep
deprivation represents an enormous
50%
risk to the developing infant; sleep
integrity is critical in brain maturation
40%
and plasticity, but more importantly,
30%
sleep deprivation is associated with
SIDS (for a more complete discussion,
20%
see Hayes et al. 2007).
In the second study, led by Dr.
10%
Brown, an interdisciplinary team of
0
doctors, nurses and researchers evaluated the effects of different drug
regimens on length of hospital stay,
withdrawal severity, and infant irritability. Between 60 and 80 percent of
opiate-exposed infants develop a condition called
neonatal abstinence syndrome (NAS), a life-threatening collection of physiological symptoms of withdrawal
(e.g., irritability, poor sleep and feeding, gastrointestinal
distress, sweating and respiratory dysfunction) between
48 and 72 hours after birth. Sixty-six percent of infants
in the study group experienced severe withdrawal
symptoms that met criteria for NAS.
Figure 1 shows differences in withdrawal treatment
based on type of addiction treatment during pregnancy.
Infant outcome is measured in number of infants
requiring no treatment, phenobarbitol, or opiate
replacement, e.g., DTO (titrated dose of tincture of
opium) or methadone. Mothers were treated with
either methadone, bupenorphine (Subutex), prescription opiates, or no treatment (self-medication or using
street drugs). While it appears that infants of mothers
maintained on methadone were more likely to need
more aggressive treatment for NAS (higher rates of
DTO/methadone), it should be noted that methadonetreated mothers generally have more complex and
longer-standing opiate addiction and other sociodemographic challenges than those on buprenorphine.

Phenobarb Only

DTO/Methadone
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52.3%

50.0%
44.4%

28.6%

27.8%
18.2%

20.5%

Methadone

22.2%

22.2%

16.7%
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14.3%

Prescription
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The differences seen in infant outcome based on
treatment history highlight the importance of characterizing both the exposure history and the withdrawal
profile of these high-risk infants. Managing and
reducing the severity of NAS through new drug regimens have been implemented and have improved
treatment and reduced the length of stay in the
hospital. In the neonatal nursery at EMMC, mothers
are strongly encouraged to breastfeed because of the
demonstrated advantages for the high-risk infant’s
developing brain and the evidence from our group and
others that withdrawal may be ameliorated by the trace
amounts of opiates present in the breast milk (AbdelLatif et al. 2006).
As part of the opiate study, the University of
Maine team in collaboration with Dr. Krishnan has
been examining opiate-exposed infants and matched
controls for early cognitive function. Over the last
decade, the behavioral and neural biomarkers to screen
for cognitive developmental risk in the newborn using
electroencephalography (EEG) cognitive testing have
emerged (Molfese 2000). We found that newborn brain
waves are predicted by prenatal exposure profiles:
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women entering opiate-replacement treatment earlier
have infants with better EEG associated with attention
and memory function. In addition, withdrawal severity
and drug replacement clearly impair the brain EEG
response acutely, and perhaps for the long term, adding
new urgency for improved pharmacological regimens
for withdrawal treatment and prenatal maternal opiate
management (Krishnan et al. 2008).
Because the population of opiate-addicted mothers
is characterized as having poor access to health care
resources, integrating child screens into narcotics treatment programs can activate mechanisms for early intervention. Under the leadership of Dr. Tisher, and in
conjunction with the well child clinic at Acadia
Hospital, the study team has established a follow-up
clinic to evaluate long-term developmental consequences of NAS. Children are assessed at seven months
using the Bayley Scales of Infant Development, which
assesses motor, cognitive, and language development
along with social and emotional functioning. In our
current cohort, 50 percent of the children screened
exhibit significant delays in motor function, an infancy
marker of developmental delay. The relationship to
withdrawal severity, prenatal methadone dose, and
other prenatal and postnatal risk factors are suggestive
but not yet clear.

Pushing back the window of child
identification to the perinatal and early
infancy period allows interventionists
to take best advantage of the explosion
of brain growth in the first three years.
Discussion
Clearly, early-early assessment is needed to
improve pharmacological methods of prenatal methadone maintenance and safe withdrawal after birth, and
to inform standards of care for these children who are
at high risk of brain injury as they age. These current
efforts to address the opiate crisis in the eastern Maine
64 · Maine Policy Review · Summer/Fall 2009

area have required tremendous focused adaptation from
our existing health care infrastructure. The cutting-edge
intervention system at Acadia Hospital is continuing to
develop innovative care of the pregnant patient and her
family in preparation for the birth of the opiateexposed infant. There are prenatal parenting groups
along with joint pediatric and NTP prenatal meetings
with health care providers to prepare for hospitalization
withdrawal complications. Additionally, the psychological adjustment to the birth of an infant, and often to
first parenthood, is difficult for any mother, but is
particularly difficult for a mother struggling with
addiction recovery and economic stress. In addition to
the typical challenges encountered by new parents,
these families are also presented with the challenge of
caring for a “temperamental” infant who suffers symptoms of withdrawal.
FUTURE DIRECTIONS AND POLICY
IMPLICATIONS

A

lthough modern medicine and intensive care
interventions for newborns have revolutionized
pediatric medicine, more efforts are needed to rehabilitate children suffering neurodevelopmental compromise. A large proportion of these complications are
related to poor maternal prenatal health and substance
abuse, often leading to ARND and in rare cases, FAS
and NAS related to opiate withdrawal. Brain injury
learning disabilities related to alcohol exposure show up
in the child as social and cognitive processing deficits
and attention-deficit hyperactivity disorder. In Maine,
prescription opiate addiction has been added to the
problem of alcohol abuse as a risk factor in early development. The brain developmental injury from these
prenatal exposures conspires with environmental risk
due to poverty to create more Maine children each year
in need of special care, which if delayed until schoolage, may lead to a lifetime of developmental disability.
High-risk infants are born to high-risk families
living in high-risk environments. Often, developmental
consequences show “sleeper” effects that emerge later in
the toddler and childhood years; that is, apparently
healthy infants may emerge as impaired at later points
in their lives. Hence, environmental risk factors may
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exacerbate preexisting prenatal risk factors when the
child returns home.
The Maine Infant Follow-up Project is now
working in collaboration with the national effort of the
Sarah Jane Foundation called the “Pediatric Acquired
Brain Injury [PABI] Plan” of intervention for brain
injury during the early years (www.thebrainproject.org).
Using cutting-edge assessment and treatment methods,
we can identify at-risk children earlier. Pushing back the
window of child identification to the perinatal and early
infancy period allows interventionists to take best advantage of the explosion of brain growth in the first three
years (Als et al. 2004).
It is well known that stimulating experiences and
opportunities to practice new abilities in all developmental domains (e.g., cognitive, language, social, and
motor) optimize brain development. Targeted early environmental enrichment that is maternal and family based
is being implemented to increase the chance of developmental catch-up and recovery, led through an expansion
of existing developmental care systems. This dynamic
intervention model is based on new research in pediatrics, developmental psychology/psychiatry, and clinical
neuroscience tied to the PABI national program for
child brain injury. A statewide effort to improve earlyearly assessment and intervention promises a larger net
for developmental catch-up, along with improved family
and school support for caregivers working with children
with brain injury. -
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